Search This Blog

Monday, September 23, 2019

ADC Therapeutics sets IPO terms

ADC Therapeutics (ADCT) will offer 8,194,000 common shares at $23 – 26 per share in its IPO. Underwriters over-allotment will be an additional ~1.2M shares.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.